ArticleCancer medicine2015

Clinical benefit in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure: a preliminary observation.

Eric T Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.